Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ames

Showing results (281-290 of 335) with videos related to

Pageof 34
Sort By:
Journal of Alzheimer'S Disease : JAD|September 6, 2011
Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle studyNoel G Faux, Kathryn A Ellis, Lorine Porter, et al.
Journal of Alzheimer'S Disease : JAD|August 4, 2020
Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive PerformanceSteve Pedrini, Eugene Hone, Veer B Gupta, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2012
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's diseaseAlan Rembach, James D Doecke, Blaine R Roberts, et al.
Science Advances|February 19, 2019
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's diseaseNicholas J Ashton, Alejo J Nevado-Holgado, Imelda S Barber, et al.
Geroscience|August 16, 2022
High polygenic risk score for exceptional longevity is associated with a healthy metabolic profileMary Revelas, Anbupalam Thalamuthu, Anna Zettergren, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 23, 2019
Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's diseaseSaori Hata, Chiori Omori, Ayano Kimura, et al.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Scientific Reports|April 1, 2016
Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adultsKaren A Mather, Anbupalam Thalamuthu, Christopher Oldmeadow, et al.
International Psychogeriatrics|November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Pageof 34

Showing results (281-290 of 335) with videos related to

Sort By:
Pageof 34
Journal of Alzheimer'S Disease : JAD|September 6, 2011
Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle studyNoel G Faux, Kathryn A Ellis, Lorine Porter, et al.
Journal of Alzheimer'S Disease : JAD|August 4, 2020
Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive PerformanceSteve Pedrini, Eugene Hone, Veer B Gupta, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2012
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's diseaseAlan Rembach, James D Doecke, Blaine R Roberts, et al.
Science Advances|February 19, 2019
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's diseaseNicholas J Ashton, Alejo J Nevado-Holgado, Imelda S Barber, et al.
Geroscience|August 16, 2022
High polygenic risk score for exceptional longevity is associated with a healthy metabolic profileMary Revelas, Anbupalam Thalamuthu, Anna Zettergren, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 23, 2019
Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's diseaseSaori Hata, Chiori Omori, Ayano Kimura, et al.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Scientific Reports|April 1, 2016
Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adultsKaren A Mather, Anbupalam Thalamuthu, Christopher Oldmeadow, et al.
International Psychogeriatrics|November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Pageof 34